The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 31, 2021

Filed:

Nov. 13, 2017
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Dong-ming Shen, Edison, NJ (US);

Thomas H. Graham, Quincy, MA (US);

Wensheng Liu, Edison, NJ (US);

Clare Tudge, Wayne, PA (US);

Andreas Verras, New York, NY (US);

Jinlong Jiang, Scotch Plains, NJ (US);

Inventors:

Dong-Ming Shen, Edison, NJ (US);

Thomas H. Graham, Quincy, MA (US);

Wensheng Liu, Edison, NJ (US);

Clare Tudge, Wayne, PA (US);

Andreas Verras, New York, NY (US);

Jinlong Jiang, Scotch Plains, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 515/08 (2006.01); C07D 409/12 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 231/56 (2006.01); C07D 405/12 (2006.01); C07D 487/04 (2006.01); C07D 417/12 (2006.01); C07D 413/12 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
C07D 515/08 (2013.01); C07D 231/56 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention relates to a compound represented by formula I': and pharmaceutically acceptable salts thereof. The compounds of formula I are inhibitors of diacylglyceride O-acyltransferase 2 ('DGAT2') and may be useful in the treatment, prevention and suppression of diseases mediated by DGAT2. The compounds of the present invention may be useful in the treatment of hepatic steatosis, diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions.


Find Patent Forward Citations

Loading…